Literature DB >> 22321038

Role of quantification of hepatic steatosis and future remnant volume in predicting hepatic dysfunction and complications after liver resection for colorectal metastases: a pilot study.

Alastair L Young1, Dan Wilson, Janice Ward, John Biglands, J Ashley Guthrie, K Rajendra Prasad, Giles J Toogood, Philip J Robinson, J Peter A Lodge.   

Abstract

OBJECTIVES: Accurate prediction of safe remnant liver volume to minimize complications following liver resection remains challenging. The aim of this study was to assess whether quantification of steatosis improved the predictive value of preoperative volumetric analysis.
METHODS: Thirty patients undergoing planned right or extended right hemi-hepatectomy for colorectal metastases were recruited prospectively. Magnetic resonance imaging was used to assess the level of hepatic steatosis and future remnant liver volume. These data were correlated with data on postoperative hepatic insufficiency, complications and hospital stay. Correlations of remnant percentage, remnant mass to patient mass and remnant mass to body surface area with and without steatosis measurements were assessed.
RESULTS: In 10 of the 30 patients the planned liver resection was altered. Moderate-severe postoperative hepatic dysfunction was seen in 17 patients. Complications arose in 14 patients. The median level of steatosis was 3.8% (range: 1.2-17.6%), but was higher in patients (n= 10) who received preoperative chemotherapy (P= 0.124), in whom the median level was 4.8% (range: 1.5-17.6%). The strongest correlation was that of remnant liver mass to patient mass (r= 0.77, P < 0.001). However, the addition of steatosis quantification did not improve this correlation (r= 0.76, P < 0.001).
CONCLUSIONS: This is the first study to combine volumetric with steatosis quantifications. No significant benefit was seen in this small pilot. However, these techniques may be useful in operative planning, particularly in patients receiving preoperative chemotherapy.
© 2012 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2012        PMID: 22321038      PMCID: PMC3371202          DOI: 10.1111/j.1477-2574.2011.00426.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  24 in total

1.  AHPBA/SSO/SSAT Consensus Conference on hepatic colorectal metastases: rationale and overview of the conference. January 25, 2006.

Authors:  Jean-Nicolas Vauthey; Michael A Choti; W Scott Helton
Journal:  Ann Surg Oncol       Date:  2006-09-02       Impact factor: 5.344

2.  The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy.

Authors:  Silvio Balzan; Jacques Belghiti; Olivier Farges; Satoshi Ogata; Alain Sauvanet; Didier Delefosse; François Durand
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

3.  Trends in long-term survival following liver resection for hepatic colorectal metastases.

Authors:  Michael A Choti; James V Sitzmann; Marcelo F Tiburi; Wuthi Sumetchotimetha; Ram Rangsin; Richard D Schulick; Keith D Lillemoe; Charles J Yeo; John L Cameron
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

4.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.

Authors:  Y Fong; J Fortner; R L Sun; M F Brennan; L H Blumgart
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

5.  Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging.

Authors:  Janice Ward; Philip J Robinson; J Ashley Guthrie; Susan Downing; Daniel Wilson; J Peter A Lodge; K Rajedra Prasad; Giles J Toogood; Judith I Wyatt
Journal:  Radiology       Date:  2005-08-26       Impact factor: 11.105

6.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

7.  The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection.

Authors:  M J Schindl; D N Redhead; K C H Fearon; O J Garden; S J Wigmore
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

8.  Portal vein embolization before right hepatectomy: prospective clinical trial.

Authors:  Olivier Farges; Jacques Belghiti; Reza Kianmanesh; Jean Marc Regimbeau; Roberto Santoro; Valérie Vilgrain; Alban Denys; Alain Sauvanet
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

9.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

10.  Impact of steatosis on perioperative outcome following hepatic resection.

Authors:  David A Kooby; Yuman Fong; Arief Suriawinata; Mithat Gonen; Peter J Allen; David S Klimstra; Ronald P DeMatteo; Michael D'Angelica; Leslie H Blumgart; William R Jarnagin
Journal:  J Gastrointest Surg       Date:  2003-12       Impact factor: 3.267

View more
  3 in total

1.  Major hepatic resection: from volumetry to liver scintigraphy.

Authors:  François-René Pruvot; Stéphanie Truant
Journal:  HPB (Oxford)       Date:  2016-09       Impact factor: 3.647

2.  Assessment of Liver Remnant Using ICG Clearance Intraoperatively during Vascular Exclusion: Early Experience with the ALIIVE Technique.

Authors:  Lawrence Lau; Christopher Christophi; Mehrdad Nikfarjam; Graham Starkey; Mark Goodwin; Laurence Weinberg; Loretta Ho; Vijayaragavan Muralidharan
Journal:  HPB Surg       Date:  2015-05-27

3.  A Nomogram Based on Preoperative Inflammatory Indices and ICG-R15 for Prediction of Liver Failure After Hepatectomy in HCC Patients.

Authors:  Tongdi Fang; Guo Long; Dong Wang; Xudong Liu; Liang Xiao; Xingyu Mi; Wenxin Su; Liuying Zhou; Ledu Zhou
Journal:  Front Oncol       Date:  2021-07-02       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.